CureVac - Hauptforum Forum: Community User: NeulingImDAX

https://www.fr.de/wissen/corona-impfstoff-curevac-nachzuegler-vorteile-impfungen-coronavirus-90325890.html

Ruudi Curevac now acknowledge that they are manufacturing- something we said back in early March :)

Apologies Ruudi. I watched CNBC today- saw the interview and waited for the article... https://www.cnbc.com/video/2021/04/08/there-needs-to-be-an-international-endeavor-to-distribute-vaccines-across-borders-curevac-ceo-says.html

Jon, this is a german press article of Apr 5th Sith nearly identical „News“ (if we still want to Name it).

Aus urheberrechtlichen Gründen möchte ich den Artikel hier nicht posten. Da müsst ihr euch zwar registrieren, um 1 Woche zu testen. Das ist aber risikolos, da ihr definitiv kein Abo eingeht. Der Artikel ist recht interessant, bestätigt im Grunde die hier angeführten Schlussfolgerungen.

https://bnn.de/nachrichten/baden-wuerttemberg/corona-impfstoff-von-curevac-aus-tuebingen-produktion-soll-im-sommer-starten

So ... und wer das Ganze nun auf deutsch lesen möchte ...

CureVac CEO Haas said the company was trying to avoid manufacturing pitfalls hit by other vaccine makers. This issue has perhaps been most notable at AstraZeneca and has put the vulnerability of global supply chains into sharp relief. “Manufacturing is certainly a struggle at the moment,” he said. “It’s not only that we are producing by ourselves, but we have an entire network in Europe, with other companies supporting us with manufacturing there as well, but it’s very hard sometimes to get the equipment, to get the facilities built-up but also the material to produce the mRNA.” “But we’re doing everything to get as many doses produced as we can,” Haas added.

CureVac’s CEO Franz-Werner Haas told CNBC Thursday that the vaccine maker was close to finalizing the recruitment for the vaccine’s Phase 3 clinical trial. Approval could come not long after, he said, given the urgent need for additional effective coronavirus vaccines and the expedited regulatory approval process. “We are expecting, according to our calculations, that towards the end of April or beginning of May that we will have the data https://www.cnbc.com/2021/04/08/covid-vaccine-maker-curevac-hopes-shot-will-get-eu-approval-in-june.html?__source=sharebar|twitter&par=sharebar

yes Ruudi Frankfurt, but traditional vaccine for Novovax and Johnson an Johnson are being made bySanofi , this came after Biden-Harris used MERCK to boost production Sanofi will provide Johnson & Johnson access to the established infrastructure and expertise of its vaccine manufacturing plant in Marcy l’Etoile, France, to formulate and fill vials of Janssen’s COVID-19 vaccine candidate in 2021, at a rate of approximately 12 million doses per month. I would go as far as saying this USA move with Vccines is a form of Economic Terrorism- cut of EU manufacturing and use it for there own people, but mainly to take advantage of a Economic Rebound that favours the USA/UK but hinders the EU

Ruudi. AZ vaccine is dead- its already had a name change Vaxzevria . It then did this https://www.nasdaq.com/articles/biotech-startup-vaccitech-confidentially-files-for-u.s.-ipo-ft-2021-04-07

Jon, soweit ich weiß, produziert Sanofi in Frankfurt-Höchst für BioNTech.

Ab Anfang 2023 ... das ist mutig: 14:37 Bau von Fabrik für Astrazeneca-Impfstoff in Dessau begonnen Das Pharmaunternehmen IDT Biologika hat in Dessau-Roßlau den Grundstein für ein weiteres Gebäude zur Impfstoffproduktion gelegt. Ab Anfang 2023 will das Unternehmen dort den Corona-Impfstoff von Astrazeneca produzieren. Insgesamt investiere das Unternehmen rund 100 Millionen Euro in den Ausbau des Standortes in Sachsen-Anhalt, sagte ein Sprecher. Damit werde das Projekt etwa doppelt so schnell umgesetzt, wie in der Branche üblich. Woher kommen die 100 Mio.?

Ruuudi today at 2:27 pm In English, hope that is okay. EU and Novovax- they have an agreement in principal- but with Pfizer-Biontech- Moderna- Sanofi taking up manufacturing facilities and raw ingridents in the EU- Novovax would be relying on CZ and UK for production. The EU as given Sanofi over $400 million for a vaccine- now Sanofi SA of France are just filling there own pockets and that of Pfizer - instead of producing vaccine for the EU... Merkel needs to whip Macron backside into shape and deal with the French

B19051 ok, das habe ich dann missverstanden 😉

Die Nebenwirkungen des Impfstoffs von Moderna und Pfizer bereiten den Hausärzten in den USA Sorgen. Todate Moderna- ist die am schlimmsten betroffene 28% der Menschen, die unter starken Kopfschmerzen, verschwommenem Sehvermögen, Myalgie und gastroentestionalen Problemen leiden. Pfizer zeigt dasselbe - aber mit 15% - Krankenhäuser in Illinois sehen mehr Patienten mit schwerwiegenden Nebenwirkungen und einer Reihe von Fällen von systemischer entzündlicher Myopathie